Literature DB >> 761713

Essential roles of insulin and glucagon in regulating glucose fluxes during exercise in dogs.

M Vranic, R Kawamori.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 761713     DOI: 10.2337/diab.28.1.s45

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  8 in total

1.  Combined effects of cold and somatostatin on glucose kinetics in dogs.

Authors:  Y Minaire; J Forichon; G Dallevet; M J Jomain
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1981

2.  Independence of circulating insulin levels of the increased glucose turnover in shivering dogs.

Authors:  Y Minaire; J Forichon; M J Jomain; G Dallevet
Journal:  Experientia       Date:  1981-07-15

Review 3.  The milieu interieur and the islets of Langerhans.

Authors:  R H Unger
Journal:  Diabetologia       Date:  1981       Impact factor: 10.122

Review 4.  Diabetes, insulin and exercise.

Authors:  E A Richter; H Galbo
Journal:  Sports Med       Date:  1986 Jul-Aug       Impact factor: 11.136

5.  The effects of post-exercise glucose and alanine ingestion on plasma carnitine and ketosis in humans.

Authors:  J I Carlin; E B Olson; H A Peters; W G Reddan
Journal:  J Physiol       Date:  1987-09       Impact factor: 5.182

6.  Absorption rates of subcutaneously injected insulin in the dog as calculated from the plasma insulin levels by means of a simple mathematical model.

Authors:  U Fischer; E J Freyse; E Jutzi; W Besch; M Raschke; S Höfer; G Albrecht
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

7.  Post-exercise ketosis in post-prandial exercise: effect of glucose and alanine ingestion in humans.

Authors:  J H Koeslag; L I Levinrad; J D Lochner; A A Sive
Journal:  J Physiol       Date:  1985-01       Impact factor: 5.182

Review 8.  Exercise prescription for individuals with metabolic disorders. Practical considerations.

Authors:  J C Young
Journal:  Sports Med       Date:  1995-01       Impact factor: 11.136

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.